CORC

在结果中检索

CORC

浏览/检索结果: 共55条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Lymphotoxin-alpha promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner 期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2019, 卷号: 145, 期号: 5
作者:  Yang, Jie-Gang;  Wang, Wei-Ming;  Xia, Hou-Fu;  Yu, Zi-Li;  Li, Hui-Min
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
Research on power wireless private network planning technology considering propagation model correction part one theory fundament (Open Access) 会议论文
作者:  Xiao, Zhenfeng;  Fan, Feng;  Zhang, Xiaoyou;  Han, Sijing;  Liao, Wei
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Inhibition of HDAC3 Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice In Vivo and In Vitro 期刊论文
JOURNAL OF DIABETES RESEARCH, 2019
作者:  Zhao, Bo;  Yuan, Quan;  Hou, Jia-bao;  Xia, Zhong-yuan;  Zhan, Li-ying
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
GRID: a student project to monitor the transient gamma-ray sky in the multi-messenger astronomy era 期刊论文
EXPERIMENTAL ASTRONOMY, 2019, 卷号: 48, 期号: 1
作者:  Wen, Jiaxing;  Long, Xiangyun;  Zheng, Xutao;  An, Yu;  Cai, Zhengyang
收藏  |  浏览/下载：143/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Yimitasvir and Sofosbuvir for HCV Genotype 1 Infection 会议论文
作者:  Luo, Bi-Fen;  Jin, Jinglan;  Rao, Huiying;  Ning, Qin;  Hou, Jinlin
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace